LU78330A1 - Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant - Google Patents
Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenantInfo
- Publication number
- LU78330A1 LU78330A1 LU78330A LU78330A LU78330A1 LU 78330 A1 LU78330 A1 LU 78330A1 LU 78330 A LU78330 A LU 78330A LU 78330 A LU78330 A LU 78330A LU 78330 A1 LU78330 A1 LU 78330A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- hydantony
- derivatives
- preparation
- new
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73306276A | 1976-10-18 | 1976-10-18 | |
| US05/767,803 US4117230A (en) | 1976-10-18 | 1977-02-11 | Hydantoin derivatives as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU78330A1 true LU78330A1 (fr) | 1979-06-01 |
Family
ID=27112515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU78330A LU78330A1 (fr) | 1976-10-18 | 1977-10-17 | Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant |
Country Status (29)
| Country | Link |
|---|---|
| JP (3) | JPS5353653A (no) |
| AR (1) | AR220901A1 (no) |
| AT (1) | AT356136B (no) |
| AU (1) | AU504978B2 (no) |
| BG (1) | BG28847A3 (no) |
| CA (1) | CA1088945A (no) |
| CH (1) | CH625511A5 (no) |
| DD (1) | DD131931A5 (no) |
| DE (4) | DE2759927C2 (no) |
| DK (1) | DK150302C (no) |
| ES (1) | ES463267A1 (no) |
| FI (1) | FI62307C (no) |
| FR (1) | FR2367754A1 (no) |
| GB (1) | GB1566171A (no) |
| GR (1) | GR70201B (no) |
| HK (1) | HK53881A (no) |
| IE (1) | IE45805B1 (no) |
| IL (1) | IL53094A0 (no) |
| KE (1) | KE3167A (no) |
| LU (1) | LU78330A1 (no) |
| MX (1) | MX4899E (no) |
| MY (1) | MY8200157A (no) |
| NL (1) | NL167434C (no) |
| NO (1) | NO148453C (no) |
| NZ (1) | NZ185358A (no) |
| PH (1) | PH15639A (no) |
| PT (1) | PT67164B (no) |
| SE (1) | SE437024B (no) |
| YU (1) | YU40821B (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
| US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
| US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
| US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
| US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
| US4283409A (en) * | 1979-10-29 | 1981-08-11 | Pfizer Inc. | Imidazolone derivatives |
| US4286098A (en) * | 1980-03-28 | 1981-08-25 | Pfizer Inc. | Process for the preparation of chiral hydantoins |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| EP0065392B1 (en) * | 1981-05-13 | 1985-02-13 | Imperial Chemical Industries Plc | Pharmaceutical compositions containing spiro succinimide derivatives |
| JPS58213717A (ja) * | 1982-01-20 | 1983-12-12 | Eisai Co Ltd | ヒダントイン誘導体を含有する治療用薬剤 |
| JPS59500617A (ja) * | 1982-04-15 | 1984-04-12 | アルコン・ラボラトリ−ズ・インコ−ポレ−テッド | ヒダントイン治療剤 |
| HU193191B (en) * | 1982-12-06 | 1987-08-28 | Pfizer | Process for preparing spiro-hetero-azolones |
| US4474967A (en) * | 1983-04-27 | 1984-10-02 | Pfizer Inc. | 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione |
| HU198051B (en) * | 1984-10-30 | 1989-07-28 | Pfizer | Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives |
| JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
| JPS6357588A (ja) * | 1986-08-28 | 1988-03-12 | Sanwa Kagaku Kenkyusho Co Ltd | ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤 |
| HU204832B (en) * | 1987-09-04 | 1992-02-28 | Pfizer | Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same |
| GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| AU2003225077A1 (en) | 2002-04-18 | 2003-11-03 | University Of Virginia Patent Foundation | Novel sodium channel blockers |
| FR2955107B1 (fr) | 2010-01-08 | 2012-03-02 | Servier Lab | Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB818724A (en) * | 1956-10-18 | 1959-08-19 | Ici Ltd | Hydantoin derivatives |
| DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
| US3532744A (en) * | 1967-07-28 | 1970-10-06 | American Home Prod | 1- and 2-amino substituted indane and tetralene carboxylic acids |
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| DE2449030A1 (de) * | 1974-10-11 | 1976-05-20 | Schering Ag | Neue pyridin-derivate |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
-
1977
- 1977-09-30 CA CA287,868A patent/CA1088945A/en not_active Expired
- 1977-10-03 SE SE7711053A patent/SE437024B/sv not_active IP Right Cessation
- 1977-10-04 GR GR54503A patent/GR70201B/el unknown
- 1977-10-05 NZ NZ185358A patent/NZ185358A/xx unknown
- 1977-10-06 AU AU29431/77A patent/AU504978B2/en not_active Expired
- 1977-10-10 YU YU2442/77A patent/YU40821B/xx unknown
- 1977-10-10 IL IL53094A patent/IL53094A0/xx not_active IP Right Cessation
- 1977-10-14 DE DE2759927A patent/DE2759927C2/de not_active Expired
- 1977-10-14 PH PH20335A patent/PH15639A/en unknown
- 1977-10-14 DE DE2746244A patent/DE2746244C2/de not_active Expired
- 1977-10-14 FI FI773060A patent/FI62307C/fi not_active IP Right Cessation
- 1977-10-14 DE DE2759542A patent/DE2759542C2/de not_active Expired
- 1977-10-14 DE DE2759543A patent/DE2759543C2/de not_active Expired
- 1977-10-15 ES ES463267A patent/ES463267A1/es not_active Expired
- 1977-10-17 CH CH1262677A patent/CH625511A5/fr not_active IP Right Cessation
- 1977-10-17 NO NO773548A patent/NO148453C/no unknown
- 1977-10-17 MX MX776490U patent/MX4899E/es unknown
- 1977-10-17 NL NL7711358.A patent/NL167434C/xx not_active IP Right Cessation
- 1977-10-17 JP JP12437177A patent/JPS5353653A/ja active Granted
- 1977-10-17 GB GB43122/77A patent/GB1566171A/en not_active Expired
- 1977-10-17 DK DK461377A patent/DK150302C/da not_active IP Right Cessation
- 1977-10-17 IE IE2114/77A patent/IE45805B1/en not_active IP Right Cessation
- 1977-10-17 PT PT67164A patent/PT67164B/pt unknown
- 1977-10-17 LU LU78330A patent/LU78330A1/xx unknown
- 1977-10-17 FR FR7731216A patent/FR2367754A1/fr active Granted
- 1977-10-18 AR AR269623A patent/AR220901A1/es active
- 1977-10-18 DD DD7700201582A patent/DD131931A5/xx unknown
- 1977-10-18 BG BG7737604A patent/BG28847A3/xx unknown
- 1977-10-18 AT AT745977A patent/AT356136B/de not_active IP Right Cessation
-
1978
- 1978-11-25 JP JP53145925A patent/JPS5940388B2/ja not_active Expired
- 1978-11-25 JP JP53145926A patent/JPS607997B2/ja not_active Expired
-
1981
- 1981-10-09 KE KE3167A patent/KE3167A/xx unknown
- 1981-11-05 HK HK538/81A patent/HK53881A/xx unknown
-
1982
- 1982-12-30 MY MY157/82A patent/MY8200157A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU78330A1 (fr) | Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant | |
| BE859824A (fr) | Nouveaux derives d'hydantoine et composition pharmaceutique les contenant | |
| BE880584A (fr) | Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant | |
| LU79685A1 (fr) | Procede de preparation de nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et de compositions pharmaceutiques les contenant | |
| BE873500A (fr) | Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant | |
| PT78340B (fr) | Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant | |
| PT85279A (fr) | Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant | |
| FR2353530A1 (fr) | Nouveaux derives de guanidine, leur procede de preparation et composition pharmaceutique les contenant | |
| PT83896A (fr) | Procede pour la preparation de nouveaux conjuges de la vinblas-tine et de ses derives et de compositions pharmaceutiques les contenant | |
| FR2411839B1 (fr) | Derives de l'acide cephalosporanique, procedes pour leur preparation et composition pharmaceutique les contenant | |
| BE861964A (fr) | Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant | |
| FR2344531A1 (fr) | Nouveaux derives de l'acide sulfonamidobenzoique, leur procede de preparation et medicaments les contenant | |
| BE892552A (fr) | Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides | |
| PT78275B (fr) | Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant | |
| BE878230A (fr) | Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant | |
| FR2333496A2 (fr) | Nouveaux derives d'ethanolamine, leur procede de preparation et composition pharmaceutique les contenant | |
| FR2335210A1 (fr) | Nouveaux sels metalliques d'acides phenylpropioniques substitues, leur procede de preparation et composition pharmaceutique les contenant | |
| FR2446819B1 (fr) | Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant | |
| FR2303559A1 (fr) | Nouveaux derives d'histidine, leur procede de preparation et composition pharmaceutique les contenant | |
| PT82364A (fr) | Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant | |
| BE884620A (fr) | Nouveaux derives d'halovincamone, leur procede de preparation et medicaments les contenant | |
| BE837698A (fr) | Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et composition pharmaceutique les contenant | |
| FR2528422B1 (fr) | Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives | |
| BE884171A (fr) | Nouveaux derives de l'ergol-8-ene et de l'ergoline, procede de preparation de ces derives et medicaments les contenant | |
| PT70005A (fr) | Procede de preparation de nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime et des compositions pharmaceutiquesles contenant |